Just weeks after unveiling its first COVID-19 vaccine prototype, the WHO's mRNA technology is moving to Asia and Europe

 So far, the initiative has generated a prototype COVID-19 vaccine that is comparable to Moderna's but not identical. It's based on the same publicly accessible sequence, but due to Moderna's unwillingness to help (beyond pledging not to pursue its patents during the epidemic), WHO partner Afrigen has had to figure out the remainder on its own. Given the dearth of assistance, it may take years for the vaccines to be mass-produ....